{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:26:42Z","timestamp":1794670002360,"version":"4.9.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The illicit injection of xylazine has recently been designated as an emerging public health threat. The use of this drug is associated with devastating soft-tissue necrosis that may lead to limb amputation. This study aimed to (1) report cases of soft-tissue injury from xylazine and (2) describe a staging and management algorithm for wounds related to xylazine use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective review was conducted to identify patients treated for xylazine-related soft-tissue necrosis at a trauma center. Clinical cases, treatment strategy, and available outcomes were presented. In addition, a comprehensive literature search was conducted using the keywords \u201cxylazine\u201d and \u201csoft tissue.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The management of seven patients with xylazine-related upper extremity soft-tissue necrosis was included, in addition to summarizing findings of five studies reporting on 13 additional cases. These cases were managed with local wound care (2 patients), soft-tissue reconstruction (4 patient), osseous reconstruction (1 patient), and limb amputation (10 patients).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Acute treatment of xylazine-related soft-tissue necrosis is ideal to minimize morbidity and prevent limb loss. Management strategies of these wounds should be based on the depth of tissue involvement. Superficial ulceration involving the skin and subcutaneous tissue (Stage 1) should be managed with local wound care. Deeper ulceration involving tendons and\/or muscle (Stage 2) requires surgical d\u00e9bridement and soft-tissue reconstruction. Deeper ulceration involving bone (Stage 3) requires osseous d\u00e9bridement and reconstruction. Finally, when all tissues in the extremity are involved (Stage 4), amputation is often necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-24-00125","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T21:42:36Z","timestamp":1724881356000},"page":"e1219-e1225","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Management of Xylazine-Induced Soft-Tissue Necrosis: A Review of 20 Cases"],"prefix":"10.5435","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-0404","authenticated-orcid":false,"given":"Helene","family":"Retrouvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyros","family":"Ipaktchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Folchert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"R1-20260601","article-title":"Biden-\u2060Harris Administration designates fentanyl combined with xylazine as an emerging threat to the United States. The White House"},{"key":"R2-20260601","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine \u2014 medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"New Engl J Med"},{"key":"R3-20260601","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J Urban Health"},{"key":"R14-20260601","doi-asserted-by":"crossref","first-page":"109380","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"R5-20260601","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: Trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am J Public Health"},{"key":"R6-20260601","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"R8-20260601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"R9-20260601","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clinica Chim Acta"},{"key":"R10-20260601","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst Abuse Treat Prev Pol"},{"key":"R11-20260601","article-title":"Animal sedative mixed with fentanyl brings fresh horror to U.S. Drug zones","year":"2023","journal-title":"New York Times"},{"issue":"2","key":"R12-20260601","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: A lesser-known entity","volume":"89","author":"Bishnoi","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R15-20260601","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMicm2303601","article-title":"Xylazine-associated skin injury","volume":"388","author":"O'Neil","year":"2023","journal-title":"N Engl J Med"},{"key":"R16-20260601","first-page":"e28160","article-title":"Xylazine-induced skin ulcers in a Person who injects drugs in Philadelphia, Pennsylvania, USA","volume":"14","author":"Malayala","year":"2022","journal-title":"Cureus"},{"key":"R17-20260601","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdcr.2023.04.010","article-title":"Xylazine-induced acute skin necrosis in two patients who inject fentanyl","volume":"36","author":"Rose","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"1","key":"R18-20260601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.58616\/surgicoll.00002","article-title":"Upper extremity soft tissue wound related to xylazine-laced fentanyl intravenous (IV) drug abuse: A case report","volume":"1","author":"Rengifo","year":"2023","journal-title":"SurgiColl"},{"key":"R19-20260601","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhsa.2023.04.001","article-title":"Necrotic upper-extremity infections in people who inject drugs: A case series","volume":"49","author":"Soderquist","year":"2024","journal-title":"J Hand Surg Am"},{"key":"R20-20260601","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodriguez","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R23-20260601","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/10550887.2012.735570","article-title":"Desomorphine goes \"crocodile\"","volume":"31","author":"Gahr","year":"2012","journal-title":"J Addict Dis"},{"key":"R25-20260601","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2013.09.030","article-title":"'Krokodil'--a designer drug from across the Atlantic, with serious consequences","volume":"127","author":"Thekkemuriyi","year":"2014","journal-title":"Am J Med"},{"key":"R21-20260601","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2018.01.029","article-title":"Experiences with skin and soft tissue infections among people who inject drugs in Philadelphia: A qualitative study","volume":"187","author":"Harris","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"R22-20260601","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/wound.2016.0697","article-title":"Review of the current management of pressure ulcers","volume":"7","author":"Boyko","year":"2018","journal-title":"Adv Wound Care"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-24-00125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:02Z","timestamp":1787669402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-24-00125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":21,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-24-00125","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"2024-01-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}